WST
West Pharmaceutical Services, Inc.
HealthcareKey Metrics
Factor Lens
Seasonal Performance
Dividends
Per-share amounts adjusted for stock splits.
Last 12 Payouts
| Period | Ex-Date | Amount / Share |
|---|---|---|
| Q1 2026 | ~2026-03-31 | $0.2200 |
| Q4 2025 | ~2025-12-30 | $0.2200 |
| Q3 2025 | ~2025-09-30 | $0.2200 |
| Q2 2025 | ~2025-06-30 | $0.2100 |
| Q1 2025 | ~2025-03-31 | $0.2100 |
| Q2 2024 | ~2024-06-30 | $0.2000 |
| Q1 2024 | ~2024-03-31 | $0.2000 |
| Q2 2023 | ~2023-06-30 | $0.1900 |
| Q1 2023 | ~2023-03-31 | $0.1900 |
| Q2 2022 | ~2022-06-30 | $0.1800 |
| Q1 2022 | ~2022-03-31 | $0.1800 |
| Q2 2021 | ~2021-06-30 | $0.1700 |
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
West Pharmaceutical Services, Inc. is a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery… systems for injectable drugs and healthcare products. The Company operates through two business segments: (1) Proprietary Products, which offers elastomers & primary containment, drug delivery devices, integrated systems, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers, including stoppers and seals for injectable packaging systems, syringe and cartridge components, vials, syringes, plungers, cartridges, and self-injection devices, as well as films, coatings, washing, vision inspection and sterilization processes; and (2) Contract-Manufactured Products, which provides fully integrated design, manufacture, and automated assembly of complex devices for pharmaceutical, diagnostic, and medical device customers, including custom contract-manufacturing and assembly solutions using multi-component molding, in-mold labeling, ultrasonic welding, and clean room molding. The Company's customers include leading biologic, generic, pharmaceutical, diagnostic, and medical device companies worldwide. West manufactures approximately 41 billion components and devices annually across 25 global manufacturing sites with over 10,000 employees, delivering thousands of injectable therapies to millions of patients daily.
- Name
- West Pharmaceutical Services, Inc.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Eric M. Green · President, Chief Executive Officer and Chair of the Board
- Employees
- 10,000 as of 2025-12-31
- IPO Date
- 2014-06-24
- Phone
- (610) 594-2900
- Address
- 530 Herman O. West Drive, Exton, PA 19341-1147
- Website
- www.westpharma.com
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Deborah L. V. Keller | Board Member | — |
| Molly E. Joseph | Board Member | — |
| Janet B. Haugen | Board Member | — |
| Mark A. Buthman | Board Member | — |
| Eric M. Green | President, Chief Executive Officer and Chair of the Board | — |
Latest News
- 2026-04-26
- 2026-04-24
- 2026-04-23
- 2026-04-23
- 2026-04-23
- 2026-04-23
- 2026-04-23
- 2026-04-23